Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00269555 · ClinicalTrials.gov registry record · NA
Effects of GCP on Prostate Cancer.
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT00269555 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 62 participants.
The verdict
NCT00269555, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
Genistein Combined Polysaccharide (GCP) is derived from adding soy powder to shiitake mushrooms. This concentrated mixture is currently being sold in Japan and the United States and is thought to possibly contain properties that may be useful in treating certain types of cancer.
Interventions
- DRUG Genistein Combined Polysaccharide (GCP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2004-05 |
| Est. Completion | 2006-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00269555
The ClinicalTrials.gov registry entry for NCT00269555 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genistein Combined Polysaccharide (GCP) is the first listed.
NCT00269555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00269555 about?
NCT00269555 is a clinical study titled "Effects of GCP on Prostate Cancer.". Genistein Combined Polysaccharide (GCP) is derived from adding soy powder to shiitake mushrooms. This concentrated mixture is currently being sold in Japan and the United States and is thought to possibly contain properties that may be useful in treating certain types of cancer.
What is the current status of trial NCT00269555?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2004-05. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00269555?
The interventions under investigation include: Genistein Combined Polysaccharide (GCP) (DRUG).
Who is sponsoring clinical trial NCT00269555?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.